Weight Loss to Prevent BCRL: A Pilot Study

Abramson Cancer Center at Penn Medicine1 site in 1 country20 target enrollmentJuly 2010

ConditionsObesity Breast Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Obesity
Sponsor: Abramson Cancer Center at Penn Medicine
Enrollment: 20
Locations: 1
Primary Endpoint: Follow-up Appts.
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to establish feasiblity of recruiting obese breast cancer survivors at the end of treatment, getting those survivors to lose weight and attend follow-up visits for 6 months.

Detailed Description

Breast cancer related lymphedema occurs in 20-30% of survivors. Weight loss could prevent onset. We seek to do a pilot study to establish feasibility of 1) recruiting survivors at risk for lymphedema to do a weight loss intervention, 2) achieving 10-15% weight loss over 26 weeks in this population, and 3) attendance at follow-up visits 6 months.

Registry

clinicaltrials.gov

Start Date

July 2010

End Date

October 2012

Last Updated

13 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

Abramson Cancer Center at Penn Medicine

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Breast Cancer Survivors who had 5 or more lymph nodes removed and radiation to lymph nodes as part of treatment.
•Completed all treatments - no metastatic cancers
•Overweight or obese (BMI greater than or equal to 25 kg/m2)
•Medically and logistically able to participate in a weight loss and exercise program over 6 months.
•Diagnosed with breast cancer within the past 2 years.

Exclusion Criteria

•More than 2 years since breast cancer diagnosis
•Medical status that would preclude safety of participation in a weight loss and exercise program
•Metastatic cancer
•Already enrolled in a weight loss program